🔎 Trials Near Me

Hjem › Multipelt myelom › Iowa

Kliniske studier for Multipelt myelom i Iowa

17 studier for Multipelt myelom søker deltakere på steder i Iowa.

Byer i Iowa

Offisiell studietekst (engelsk)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  • University of Iowa Hospitals and Clinics, Iowa City
  • Mission Cancer Blood University of Iowa Health Care, Waukee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  • University of Iowa Hospital and Clinics, Iowa City
  • Mission Cancer Blood, Waukee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07258511

Collection of Tissue Samples for Cancer Research

  • University of Iowa, Iowa City
RekruttererObservasjonsstudie
2 Months · Alle kjønn · Oppdatert 16. sep. 2026 · NCT00900198

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • University of Iowa, Iowa City
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06297226

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Mary Greeley Medical Center, Ames
  • McFarland Clinic - Ames, Ames
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
  • og 18 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04566328

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

  • Research Site, Iowa City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05850234

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

  • Research Site, Iowa City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT07764978

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  • University of Iowa, Iowa City
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07284758

Integrated Cancer Repository for Cancer Research

  • Methodist Jennie Edmundson Hospital, Council Bluffs
  • Covenant Medical Center, Inc, Waterloo
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Mission Cancer and Blood - Ankeny, Ankeny
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
  • Physicians' Clinic of Iowa PC, Cedar Rapids
  • og 7 flere
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT05561387

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

  • University of Iowa, Iowa City
RekruttererFase 2
Alder 19 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06974786

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

  • University of Iowa Health Care, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT07581704

Sleep Apnea in Patients With MGUS and MM

  • University of Iowa, Iowa City
RekruttererObservasjonsstudie
Alder 18 til 99 · Alle kjønn · Oppdatert 10. nov. 2025 · NCT04114084

Activity Levels in Bone Marrow Transplant Patients

  • University of Iowa, Iowa City
RekruttererObservasjonsstudie
Alder 18 til 99 · Alle kjønn · Oppdatert 10. nov. 2025 · NCT04115241

Limited-duration Teclistamab

  • University of Iowa Hospitals and Clinics, Iowa City
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2025 · NCT05932680

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.